appeal Archives - King & Wood Mallesons Pulse

The penultimate instalment in the “admissibility or jurisdiction debate” in Hong Kong: permission to appeal to the Court of Final Appeal granted in C v D

16 January 2023

The Court of Final Appeal has granted leave to appeal in the case of Cv D which deals with the issue of admissibility or jurisdiction

Read on

Mazda and the ACCC race to win appeal in the Full Federal Court

10 May 2022

By Wilson Huang

Both the ACCC and Mazda have appealed a Federal Court decision which found that Mazda had mislead consumers but not acted unconscionably...

Read on

Appealing domestic arbitral awards in Australia: not opting out is not opting in

3 December 2020

By Lucy Forbes

This article provides a summary of Jacobs Group v Commonwealth Australia and its implications on the appeal of domestic arbitral awards in Australia

Read on

The Appeal of the Law: Singapore’s decision to hold off introduction option to appeal on point of law and other changes

1 November 2020

By Patric McGonigal

The right to appeal an arbitral award on questions of law is not uncommon. Singapore has yet to adopt this right into its IAA legislation.

Read on

A very modest win: Generic Health gets 2% cut to Bayer’s $25 million damages

8 November 2018

By Esme Wong

Last year, Bayer was awarded more than $25 million (plus interest and indemnity costs) against Generic Health in the first Federal Court award of damages for pharmaceutical patent infringement.

Read on

Smells fishy: Trident Seafoods Corporation v Trident Foods Pty Limited

19 October 2018

By Diana Liu

This recent Federal Court decision concerns two appeals by Trident Seafoods Corporation (Trident Seafoods) from decisions made by delegates of the Registrar of Trade Marks.

Read on

United States Court of Appeals upholds PTAB decision on CRISPR Patent Interference

24 September 2018

By Veg Tran

Regents of the University of California & Ors v Broad Institute, Inc.

Read on

What do you know about a ‘smoking gun’?

5 June 2018

By Tamara Hunter

The Full Court of the Federal Court has handed down its decision in the ACCC's appeal of the Pfizer case. The case considers 'smoking gun' documents.

Read on

Second throw of the dice unsuccessful: Full Federal Court confirms Hepatitis C drug patent is invalid

21 December 2017

By Suzy Madar

The recent decision of the Full Court in Idenix Pharmaceuticals v Gilead Sciences [2017] FCAFC 196 illustrates the power of the grounds of lack of utility and lack of sufficiency under section 40 of the Patents Act when challenging the validity of a patent.

Read on

Full Court warns against dangerous affliction of parameteritis (and confirms invalidity of aripiprazole patent)

26 August 2016

By Suzy Madar

On Wednesday the Full Court of the Federal Court of Australia handed down a decision in which it upheld Justice Yates’ findings that Otsuka’s patent relating to aripiprazole, a drug used in the treatment of schizophrenia, is invalid for want of novelty and inventive step.

Read on